Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation
Rattachement africain : cn, nl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Dried blood spot (DBS) sampling and high-performance liquid chromatography tandem-mass spectrometry have been developed in monitoring tacrolimus levels. Our center favors the use of limited sampling strategy and abbreviated formula to estimate the area under concentration-time curve (AUC(0-12)). However, it is inconvenient for patients because they have to wait in the center for blood sampling. We investigated the application of DBS method in tacrolimus level monitoring using limited sampling strategy and abbreviated AUC estimation approach. Duplicate venous samples were obtained at each time point (C(0), C(2), and C(4)). To determine the stability of blood samples, one venous sample was sent to our laboratory immediately. The other duplicate venous samples, together with simultaneous fingerprick blood samples, were sent to the University of Maastricht in the Netherlands. Thirty six patients were recruited and 108 sets of blood samples were collected. There was a highly significant relationship between AUC(0-12), estimated from venous blood samples, and fingerprick blood samples (r(2) = 0.96, P < 0.0001). Moreover, there was an excellent correlation between whole blood venous tacrolimus levels in the two centers (r(2) = 0.97; P < 0.0001). The blood samples were stable after long-distance transport. DBS sampling can be used in centers using limited sampling and abbreviated AUC(0-12) strategy as drug monitoring.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation
- Date Crossref
- 17/10/2007
- Éditeur
- Frontiers Media SA
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Queen Elizabeth Hospital Department of Medicine pays non établi dans la noticeÉtablissement de santé
-
Maastricht University Medical Centre pays non établi dans la noticeOrganisme public
-
University Hospital Maastricht Department of Clinical Pharmacy pays non établi dans la noticeUniversité ou école supérieure
Department of Medicine — Queen Elizabeth Hospital, Maastricht University Medical Centre et Department of Clinical Pharmacy — University Hospital Maastricht.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.